Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Naveed Masani"'
Publikováno v:
Journal of Intensive Care Medicine. 37:764-768
Purpose Safety of remdesivir in patients with renal impairment is unknown. Incidence of liver injury secondary to remdesivir is also unknown. The objective of this study is to assess the incidence of acute kidney injury (AKI) and to trend the liver e
Autor:
Naveed Masani, Shan Wang, Louis Dellafera, Brian Malone, Meredith Akerman, Paula Dutka, Lameesa Dhanani
Publikováno v:
Hosp Pharm
Dialysis patients are often iron deficient due to a multiple factors. Ferric pyrophosphate citrate is a complex iron salt that can be given via dialysate allowing maintenance of hemoglobin (Hgb) concentration and iron balance while reducing the need
Autor:
Naveed Masani, James Drakakis, Jasmin Divers, Elain Wu, Shahidul Islam, Nobuyuki Miyawaki, John Carson, Stephen C. Yang, Louis J. Imbriano, Paula Dutka, Imran Jawaid, Candace Grant, Minesh Khatri, Nicole Ali, Tapan H. Mehta
Publikováno v:
Kidney360
BACKGROUND: Patients on maintenance hemodialysis are particularly vulnerable to infection and hospitalization from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Due to immunocompromised patients and the clustering that occurs in outpa
Publikováno v:
Critical Care Medicine. 50:438-438
Publikováno v:
Critical Care Medicine. 49:551-551
Publikováno v:
Nephrology newsissues. 26(1)
The Centers for MedicareMedicaid Services End-Stage Renal Disease Quality Incentive Program is a pay-for-performance initiative that imposes dialysis payment reductions of up to 2% for suboptimal quality. In payment years 2012 and 2013 the methodolog